Jingmin Zhou

999 total citations
34 papers, 498 citations indexed

About

Jingmin Zhou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Jingmin Zhou has authored 34 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 18 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Jingmin Zhou's work include Cardiovascular Function and Risk Factors (11 papers), Cancer-related molecular mechanisms research (8 papers) and Cardiac Fibrosis and Remodeling (5 papers). Jingmin Zhou is often cited by papers focused on Cardiovascular Function and Risk Factors (11 papers), Cancer-related molecular mechanisms research (8 papers) and Cardiac Fibrosis and Remodeling (5 papers). Jingmin Zhou collaborates with scholars based in China, Sweden and United Kingdom. Jingmin Zhou's co-authors include Mingqiang Fu, Junbo Ge, Jingfeng Wang, Yanyan Wang, Guanghua Liu, Kai Hu, Jingjing Zhang, Junbo Ge, Xin Zhao and Zixing Ye and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Jingmin Zhou

32 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingmin Zhou China 14 240 207 126 62 58 34 498
Ruizhen Chen China 9 317 1.3× 260 1.3× 181 1.4× 76 1.2× 31 0.5× 24 584
Xiaosheng Hu China 12 220 0.9× 136 0.7× 73 0.6× 67 1.1× 38 0.7× 29 470
Xiao Ping Ji China 12 131 0.5× 190 0.9× 92 0.7× 112 1.8× 44 0.8× 13 431
Chun Xi Liu China 13 179 0.7× 381 1.8× 74 0.6× 122 2.0× 56 1.0× 15 654
Zhongwen Qi China 13 330 1.4× 116 0.6× 107 0.8× 64 1.0× 39 0.7× 18 500
Linmao Lyu China 6 245 1.0× 139 0.7× 84 0.7× 32 0.5× 34 0.6× 8 372
Na Zhou China 13 277 1.2× 124 0.6× 104 0.8× 67 1.1× 45 0.8× 35 537
Hehe Cui China 12 133 0.6× 195 0.9× 93 0.7× 45 0.7× 20 0.3× 20 372
Zhongqi Yang China 14 313 1.3× 127 0.6× 134 1.1× 47 0.8× 134 2.3× 24 589
Zhaofen Zheng China 9 157 0.7× 86 0.4× 89 0.7× 39 0.6× 53 0.9× 41 320

Countries citing papers authored by Jingmin Zhou

Since Specialization
Citations

This map shows the geographic impact of Jingmin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmin Zhou more than expected).

Fields of papers citing papers by Jingmin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingmin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmin Zhou. The network helps show where Jingmin Zhou may publish in the future.

Co-authorship network of co-authors of Jingmin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jingmin Zhou. A scholar is included among the top collaborators of Jingmin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingmin Zhou. Jingmin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qi, Baozhen, Yu Song, Shaowen Liu, et al.. (2024). Blocking NaV1.8 regulates atrial fibrillation inducibility and cardiac conduction after myocardial infarction. BMC Cardiovascular Disorders. 24(1). 605–605.
3.
Li, Fuhai, Jingfeng Wang, Yu Song, et al.. (2021). Qiliqiangxin alleviates Ang II-induced CMECs apoptosis by downregulating autophagy via the ErbB2-AKT-FoxO3a axis. Life Sciences. 273. 119239–119239. 9 indexed citations
4.
Wang, Yanyan, Mingqiang Fu, Jingfeng Wang, et al.. (2020). Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF‐1α‐Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction. BioMed Research International. 2020(1). 1276195–1276195. 14 indexed citations
5.
Wang, Yanyan, Yuyuan Fan, Yu Song, et al.. (2019). Angiotensin II induces apoptosis of cardiac microvascular endothelial cells via regulating PTP1B/PI3K/Akt pathway. In Vitro Cellular & Developmental Biology - Animal. 55(10). 801–811. 14 indexed citations
6.
Wang, Jingfeng, Zhiming Li, Yanyan Wang, et al.. (2017). Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 3197320–3197320. 14 indexed citations
7.
Liu, Guanghua, et al.. (2017). Renal hybrid oncocytic/chromophobe tumor associated with multiple schwannomas. Medicine. 96(48). e8939–e8939. 3 indexed citations
8.
Fu, Michael, Jingmin Zhou, Erik Thunström, et al.. (2016). Optimizing the Management of Heart Failure With Preserved Ejection Fraction in the Elderly by Targeting Comorbidities (OPTIMIZE-HFPEF). Journal of Cardiac Failure. 22(7). 539–544. 24 indexed citations
9.
Bai, Yingnan, Xingxu Wang, Li Shen, et al.. (2016). Mechanical Stress Regulates Endothelial Progenitor Cell Angiogenesis Through VEGF Receptor Endocytosis. International Heart Journal. 57(3). 356–362. 9 indexed citations
10.
Cui, Xiaotong, Jingmin Zhou, Xuejuan Jin, et al.. (2016). Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents. International Journal of Cardiology. 227. 820–825. 5 indexed citations
11.
Zhou, Jingmin, Xiaotong Cui, & Junbo Ge. (2015). [The epidemiological profile of heart failure patients in China].. PubMed. 43(12). 1018–21. 5 indexed citations
12.
Ye, Yong, Hui Gong, Xingxu Wang, et al.. (2015). Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice. Journal of Cardiovascular Pharmacology. 65(6). 628–639. 14 indexed citations
13.
Wang, Jingfeng, Jingmin Zhou, Kun Jiang, et al.. (2015). Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.. PubMed. 8(6). 6596–606. 27 indexed citations
14.
Zhou, Jingmin, Xiaotong Cui, Xuejuan Jin, et al.. (2014). Association of Renal Biochemical Parameters with Left Ventricular Diastolic Dysfunction in a Community-Based Elderly Population in China: A Cross-Sectional Study. PLoS ONE. 9(2). e88638–e88638. 11 indexed citations
15.
Xie, Xinzhou, et al.. (2013). Impact of Coronary Tortuosity on Coronary Blood Supply: A Patient-Specific Study. PLoS ONE. 8(5). e64564–e64564. 35 indexed citations
16.
Fu, Mingqiang, Jingmin Zhou, Juying Qian, et al.. (2012). Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study. Lipids in Health and Disease. 11(1). 106–106. 12 indexed citations
17.
Zou, Yunzeng, Lin Li, Yong Ye, et al.. (2011). Qiliqiangxin Inhibits the Development of Cardiac Hypertrophy, Remodeling, and Dysfunction During 4 Weeks of Pressure Overload in Mice. Journal of Cardiovascular Pharmacology. 59(3). 268–280. 53 indexed citations
18.
Zhou, Jingmin, et al.. (2011). [Association between the urinary microalbumin/creatinine ratio and cardiovascular risk factors among elderly community subjects].. PubMed. 39(5). 463–7. 1 indexed citations
19.
Chen, Wei, Xin Sun, Wenjian Wang, et al.. (2008). [Effects of tongxinluo capsule on cardiac ventricle remodeling after myocardial infarction: a multicentre clinical research].. PubMed. 88(32). 2271–3. 7 indexed citations
20.
Zhou, Jingmin, et al.. (2000). [The expression of platelet-derived endothelial cell growth factor in liver cancer].. PubMed. 80(11). 831–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruizhen Chen Breakdown of academic impact, for papers by Xiaosheng Hu Breakdown of academic impact, for papers by Xiao Ping Ji Breakdown of academic impact, for papers by Chun Xi Liu Breakdown of academic impact, for papers by Zhongwen Qi Breakdown of academic impact, for papers by Linmao Lyu Breakdown of academic impact, for papers by Na Zhou Breakdown of academic impact, for papers by Hehe Cui Breakdown of academic impact, for papers by Zhongqi Yang Breakdown of academic impact, for papers by Zhaofen Zheng
Rankless by CCL
2026